603669 灵康药业
2026/09 - 九个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)5.002-27.803-15.377-14.668-15.104
总资产报酬率 ROA (%)2.823-16.362-9.081-8.707-8.964
投入资产回报率 ROIC (%)3.234-19.197-10.029-9.094-9.260

边际利润分析
销售毛利率 (%)48.30443.71346.88146.67267.809
营业利润率 (%)9.060-60.770-33.906-75.690-65.226
息税前利润/营业总收入 (%)13.562-40.554-33.207-76.447-65.670
净利润/营业总收入 (%)8.836-59.922-34.431-76.967-67.711

收益指标分析
经营活动净收益/利润总额(%)95.82886.85667.780103.96389.066
价值变动净收益/利润总额(%)-4.1051.5395.3399.6284.300
营业外收支净额/利润总额(%)-1.218-1.271-0.8141.3080.069

偿债能力分析
流动比率 (X)1.2491.0982.6753.6263.743
速动比率 (X)1.0980.9222.5483.3933.581
资产负债率 (%)43.16343.95638.68142.69038.849
带息债务/全部投入资本 (%)34.91934.20026.49839.19036.010
股东权益/带息债务 (%)184.288189.971274.441153.346176.783
股东权益/负债合计 (%)131.682127.500158.526134.249157.405
利息保障倍数 (X)2.941-2.085-78.049-310.910164.745

营运能力分析
应收账款周转天数 (天)218.727278.698145.938143.506134.245
存货周转天数 (天)112.506110.97675.527181.612194.865